OVERVIEW   |   TEAM   |   NEWS

Team

An expert team of bioprocessing scientists and industry leaders who are deeply engaged in the scientific pursuit of growing a platform biotechnology company that enables next-generation biopharmaceutical manufacturing technologies to impact patients’ lives.

MANAGEMENT TEAM

Kevin Isett, PhD

Chief Executive Officer, CoFounder

bio
Adimab – Head of High Throughput Manufacturing

Merck – 10+ Years with Merck Biologics & Vaccines Research and Bioprocess R&D

Merck – Senior Engineer at Merck Bioprocess R&D, Automated & High-throughput Bioprocess Technologies

Dartmouth College, Thayer Engineering School – Merck-Sponsored Doctoral Fellow

Warren Kett, PhD

Chief Scientific Officer, CoFounder

bio
Dartmouth College, Thayer Engineering School – Senior Research Fellow

Glycan Biosciences – Co-Founder and CTO

GlycoFi (Acquired by Merck in 2006) – Senior Chemist

Tillman Gerngross, PhD

Chairman of the Board, CoFounder

bio
Adimab – Co-Founder and CEO

Alector – Co-Founder and Chairman of the Board

Arsanis – Co-Founder and President

GlycoFi (Acquired by Merck in 2006) – Co-Founder and CSO

Dartmouth College – Professor of Bioengineering and Associate Provost of the Office of Entrepreneurship and Technology Transfer

SV Life Sciences – Venture Partner

Scott Kennedy

Chief Financial Officer
bio
20+ years in executive life science finance operations

PerkinElmer

McGladrey & Pullen

University of Minnesota

Kimberly Cornwell

General Counsel
bio

Outside GC

Sanofi Pasteur

Acambis

Edwards and Angell

Boston University School of Law

Karol Lacki, PhD

VP Technology Development
bio
20+ years in developing and modeling biopharmaceutical separation technologies and manufacturing processes

Novo Nordisk A/S – Director Mathematical Modeling

GE Healthcare Life Sciences – Customer Collaboration Leader

Amersham Pharmacia Biotech – Polymer and Surface Chemistry

Grant Espie

Head of Resin Manufacturing
bio
20+ years in bioprocess chromatography and manufacturing experience

Dupont – Principal Investigator

EMD Chemicals Inc. – Technical Manager

Novasep Inc. – Engineering Manager

Nick Russell

Head of Business Development

bio

Pall Biotech (Acquired by Danaher Corporation)

Pfizer

University of Missouri

Brittany Crocco

Head of Quality

bio

Agilent Technologies – Nucleic Acid Solutions

Nitto Denko – Kinovate Life Sciences

University of the Sciences in Philadelphia

Certifications: ASQ, CMQ/OE, CQA

BOARD OF DIRECTORS
Tillman Gerngross, PhD
Co-Founder and Chairman of Avitide, Inc.
  • Co-Founder and Chief Executive Officer, Adimab LLC
  • Co-Founder and CSO, GlycoFi Inc. (acquired by Merck 2006)
  • Co-Founder, Chairman of Arsanis Inc. (merged with NASDAQ:XFOR in 2019)
  • Co-Founder, Chairman of Avitide
  • Co-Founder, Chairman of Alector (NASDAQ: ALEC)
  • Professor of Bioengineering, Dartmouth College
  • Venture Partner, SV Life Sciences
Kevin Isett, PhD
Co-Founder, CEO
  • Head of High Throughput Manufacturing, Adimab
  • 10+ Years with Merck Biologics & Vaccines Research and Bioprocess R&D
  • Senior Engineer at Merck Bioprocess R&D, Automated & High-throughput Bioprocess Technologies
  • Dartmouth College, Thayer Engineering School: Merck-Sponsored Doctoral Fellow
Phil Ferneau, MBA, J.D.
Board Director, Avitide Inc.
  • Managing Director and Co-Founder, Borealis Ventures
  • Board Director, Compass Therapeutics
  • Board Director, Orbit Discovery Ltd.
  • Founding Executive Director, Dartmouth’s Tuck School of Business Center for Private Equity and Entrepreneurship
  • A.B. Dartmouth College
  • J.D. University of Virginia School of Law
  • M.B.A. Tuck School of Business at Dartmouth
Rishi Gupta, J.D.
Board Director, Avitide Inc.
  • Partner, OrbiMed
  • Board Director, EnLiven Therapeutics
  • Board Director, Modis Therapeutics
  • Board Director, NeuroPace
  • Board Director, Pionyr Immunotherapeutics
  • Board Director, Turnstone Biologics
  • Board Director, Verona Pharma
  • Healthcare Investment Banker, Raymond James & Associates
  • Corporate Development Manager, Veritas Medicine
  • A.B. Harvard College
  • J.D. Yale Law School
Claudio Nessi, MBA, Ph.D.
Board Director, Avitide Inc.
  • Managing Partner, NeoMed Management
  • Managing Director, Omega Funds
  • Board Director, Anaconda BioMed S.L.
  • Board Director, GenKyoTex SA
  • Board Director, Arsanis Inc. (merged with NASDAQ:XFOR in 2019)
  • Board Director, Axovan SA
  • Board Director, Creabilis SA
  • Board Director, Endosense SA
  • Board Director, Kuros BioSurgery AG
  • Board Director, PregLem SA
  • M.B.A. Erasmus University
  • Ph.D. University of Pavia
Ian Ratcliffe, MBA
Board Director, Avitide Inc.
  • Managing Partner, Sands Capital Ventures
  • Board Chairman & CEO, Asterand Biosciences Inc.
  • Board Chairman & CEO, Enzymatics Inc.
  • President. Upstate Biotechnology Inc.
  • BEng. University of Surrey
  • M.B.A. Darden School, University of Virginia
Ajay Royan
Board Director, Avitide Inc.
  • Managing General Partner and Founder, Mithril Capital Management
  • Board Director, Adimab LLC
  • Board Director, AppDirect
  • Board Director, Auris Health Inc.
  • Board Director C2F0
  • Managing Director, Clarium Capital Management
  • Scientific Advisory Board Member, Oak Ridge National Laboratory
  • B.A. Yale University

Investors

16 Cavendish Court
Lebanon, NH 03766

603.965.2100
email us

© 2019 Avitide
All Rights Reserved